Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thymidine‑5'‑thiophosphate is a synthetic nucleotide analog in which the phosphate group at the 5' position of thymidine is replaced by a thiophosphate group. It belongs to the class of pyrimidine 2'-deoxyribonucleosides and has been studied as an experimental small molecule. Thymidine analogs are often used in biochemical research to probe DNA synthesis and repair mechanisms or as potential inhibitors of viral polymerases. Recent computational studies have identified thymidine‑5'‑thiophosphate as a potential inhibitor of SARS-CoV‑2 RNA-dependent RNA polymerase through molecular docking and dynamics simulations; however, there are no approved clinical uses for this compound[1][10][8]. Its mechanism may involve competitive inhibition at nucleic acid processing enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thymidine-5'-thiophosphate.